{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:25:41Z","timestamp":1794842741097,"version":"4.9.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Aging clocks tag the actual underlying age of an organism and its discrepancy with chronological age and have been reported to predict incident disease risk in the general population. However, the relationship with neurodegenerative risk and in particular with Parkinson\u2019s Disease (PD) remains unclear, with few discordant findings reporting associations with both incident and prevalent PD risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To clarify this relationship, we computed a common aging clock based on blood markers and tested the resulting discrepancy with chronological age (\u0394PhenoAge) for association with both incident and prevalent PD risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a large Italian population cohort - the Moli-sani study (N=23,437; age \u2265 35 years; 52% women) - we carried out both Cox Proportional Hazards regressions modelling \u0394PhenoAge as exposure and incident PD as outcome, and linear models testing prevalent PD as exposure and \u0394PhenoAge as outcome. All models were incrementally adjusted for age, sex, education level completed and other risk\/protective factors previously associated with PD risk in the same cohort (prevalent dysthyroidism, hypertension, diabetes, use of oral contraceptives, exposure to paints, daily coffee intake and cigarette smoking).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No significant association between incident PD risk (209 cases, median (IQR) follow-up time 11.19 (2.03) years) and PhenoAging was observed (Hazard Ratio [95% Confidence Interval] = 0.98 [0.71; 1.37]). However, a small but significant increase of \u0394PhenoAge was observed in prevalent PD cases vs healthy subjects (\u03b2 (Standard Error) = 1.39 (0.70)). An analysis of each component biomarker of PhenoAge revealed a significant positive association of prevalent PD status with red cell distribution width (RDW; \u03b2 (SE) = 0.46 (0.18)). All the remaining markers did not show any significant evidence of association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The reported evidence highlights systemic effects of prevalent PD status on biological aging and red cell distribution width. Further cohort and functional studies may help shedding a light on the related pathways altered at the organism level in prevalent PD, like red cells variability, inflammatory and oxidative stress mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2024.1376545","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T08:10:25Z","timestamp":1712736625000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Blood-based biological ageing and red cell distribution width are associated with prevalent Parkinson\u2019s disease: findings from a large Italian population cohort"],"prefix":"10.3389","volume":"15","author":[{"given":"Alessandro","family":"Gialluisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonsina","family":"Tirozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ilenia","family":"De Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Belvisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Magnacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"De Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Falciglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moreno","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cerletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Benedetta","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"de Gaetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia","family":"Iacoviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318293e2ce","article-title":"The coming crisis: obtaining care for the growing burden of neurodegenerative conditions","volume":"80","author":"Dorsey","year":"2013","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat Aging"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-330931","article-title":"Epigenetic clocks in neurodegenerative diseases: a systematic review","volume":"94","author":"Yang","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.18632\/aging.v7i12","article-title":"Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients","volume":"7","author":"Horvath","year":"2015","journal-title":"Aging (Albany NY)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s12864-021-08009-y","article-title":"Accelerated hematopoietic mitotic aging measured by DNA methylation, blood cell lineage, and Parkinson's disease","volume":"22","author":"Paul","year":"2021","journal-title":"BMC Genomics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.18632\/aging.v10i4","article-title":"An epigenetic biomarker of aging for lifespan and healthspan","volume":"10","author":"Levine","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29157","article-title":"Epigenetic clock acceleration is linked to age at onset of Parkinson\u2019s disease","volume":"37","author":"Tang","year":"2022","journal-title":"Mov Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.18632\/aging.v11i2","article-title":"DNA methylation GrimAge strongly predicts lifespan and healthspan","volume":"11","author":"Lu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1321246","article-title":"Assessing causal associations between neurodegenerative diseases and neurological tumors with biological aging: a bidirectional Mendelian randomization study","volume":"17","author":"Zhang","year":"2023","journal-title":"Front Neurosci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gly005","article-title":"Population specific biomarkers of human aging: A big data study using South Korean, Canadian, and Eastern European patient populations","volume":"73","author":"Mamoshina","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.18632\/aging.v8i5","article-title":"Deep biomarkers of human aging: Application of deep neural networks to biomarker development","volume":"8","author":"Putin","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10654-021-00797-7","article-title":"Exploring domains, clinical implications and environmental associations of a deep learning marker of biological ageing","volume":"37","author":"Gialluisi","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.3390\/ijms21228817","article-title":"Beyond haemostasis and thrombosis: platelets in depression and its co-morbidities","volume":"21","author":"Izzi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00384","article-title":"C-reactive protein and risk of Parkinson's disease: A systematic review and meta-analysis","volume":"10","author":"Qiu","year":"2019","journal-title":"Front Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28685","article-title":"Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson's disease","volume":"36","author":"Mu\u00f1oz-Delgado","year":"2021","journal-title":"Mov Disord"},{"key":"B17","article-title":"The Moli-Sani Project, a randomized, prospective cohort study in the Molise region in Italy; design, rationale and objectives","volume":"4","author":"Iacoviello","year":"2007","journal-title":"Ital J Public Health"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11803-1","article-title":"Risk and protective factors in Parkinson's disease: a simultaneous and prospective study with classical statistical and novel machine learning models","volume":"270","author":"Gialluisi","year":"2023","journal-title":"J Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v074.i07","article-title":"Imputation with the R package VIM","volume":"74","author":"Kowarik","year":"2016","journal-title":"J Stat Software"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz020","article-title":"Methylation-based biological age and breast cancer risk","volume":"111","author":"Kresovich","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-019-01197-1","article-title":"Red cell distribution width levels in Parkinson's disease patients","volume":"120","author":"Kenangil","year":"2020","journal-title":"Acta Neurol Belg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2012.10.002","article-title":"Is increased red cell distribution width (RDW) indicating the inflammation in Alzheimer's disease (AD)","volume":"56","author":"\u00d6zt\u00fcrk","year":"2013","journal-title":"Arch Gerontology Geriatrics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-019-01197-1","article-title":"Red cell distribution width levels in Parkinson\u2019s disease patients","volume":"120","author":"Kenangil","year":"2020","journal-title":"Acta Neurologica Belgica"},{"key":"B24","doi-asserted-by":"publisher","first-page":"106844","DOI":"10.1016\/j.clineuro.2021.106844","article-title":"Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review)","volume":"208","author":"Wang","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185083","article-title":"Red blood cell distribution width: Genetic evidence for aging pathways in 116,666 volunteers","volume":"12","author":"Pilling","year":"2017","journal-title":"PloS One"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1376545\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T08:10:29Z","timestamp":1712736629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1376545\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":25,"alternative-id":["10.3389\/fendo.2024.1376545"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1376545","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2024.1376545.s001","asserted-by":"subject"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"article-number":"1376545"}}